News and events

Durable clinical outcomes and outstanding valve performance Evolut™ TAVR

30 March 2025

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

The Evolut TAVR™ demonstrate superior valve performance for system in small annulus patients

09 March 2025

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients

Symplicity Spyral™ renal denervation system

09 December 2024

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years

Prevail™ Paclitaxel Coated PTCA Balloon Catheter

10 June 2024

We are glad to inform you about the appearance of a new product from Medtronic coronary direction- Prevail™ Paclitaxel Coated PTCA Balloon Catheter

Сonclusion of a distribution agreement with Shunmei Medical Co., Ltd

10 April 2024

ProCardio LLC informs about the signing of a distribution agreement with Shunmei Medical Co., Ltd.

SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus

09 April 2024

Medtronic plc, a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at the American College of Cardiology Annual Scientific Session and in The New England Journal of Medicine.